Dr. Rosenthal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 The Vanderbilt Clinic
Nashville, TN 37232Phone+1 615-322-3000
Summary
- Eben L. Rosenthal is a surgeon-scientist who serves as the Guy Maness Professor and Chair of Otolaryngology. His primary interests are free flap surgery and molecular imaging. He continues to be clinically active as an oncologic and microvascular reconstructive surgeon. He was previously the John and Ann Doerr Medical Director of the Stanford Cancer Center from 2015-2021.
Dr. Rosenthal has been continually funded by the NIH for the past 15 years to conduct bench to bedside translational studies in targeted therapy and molecular imaging. He has conducted over a dozen early phase clinical trials for diagnostic and therapeutic agents for the treatment of solid tumors. He is part of a multidisciplinary team of clinicians and basic scientists that perform preclinical animal studies including nonhuman primate IND-enabling studies, and first-in-human clinical trials. The team assesses near infrared fluorescent contrast agents for use in the operating room to make the cancer visible. Ongoing clinical trials include brain, lung, pancreas, skin and head and neck tumors. The lab also focuses on molecular imaging of fluorescently labeled therapeutic antibodies to measure cellular delivery of therapies to tumors and adjacent tissues.
Dr. Rosenthal grew up in Ann Arbor, Michigan and went to Medical School and Residency at the University of Michigan after attending Haverford College for his undergraduate education
Education & Training
- University of MichiganResidency, Otolaryngology - Head and Neck Surgery, 1995 - 2000
- University of Michigan Health SystemInternship, Transitional Year, 1994 - 1995
- University of Michigan Medical SchoolClass of 1994
Certifications & Licensure
- OR State Medical License 2000 - Present
- TN State Medical License 2021 - 2026
- CA State Medical License 2015 - 2025
- AL State Medical License 2001 - 2015
- MI State Medical License 1997 - 2002
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery
- America's Top Doctors Castle Connolly, 2012-2014
- Join now to see all
Clinical Trials
- A Trial of Erlotinib + Radiotherapy for Cutaneous Squamous Cell Carcinoma Start of enrollment: 2006 Aug 01
- UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer Start of enrollment: 2007 Dec 01
- Cetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical Procedures Start of enrollment: 2015 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Visual pathology reports for communication of final margin status in laryngeal cancer surgery.Marina Aweeda, Carly Fassler, Alexander N Perez, Alexis Miller, Kavita Prasad
Journal of Pathology Informatics. 2024-12-01 - 2 citationsHow far are we off? Analyzing the accuracy of surgical margin relocation in the head and neck.Alexis Miller, Vickie Wang, Victor Jegede, Fabian Necker, Joseph Curry
Head & Neck. 2024-11-01 - Evolving Management of Head and Neck Cancers.Sarah L Rohde, Eben L Rosenthal
Surgical Oncology Clinics of North America. 2024-10-01
Journal Articles
- Correction to: ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer SurgeryEben Rosenthal, MD, Annals of Surgical Oncology
Press Mentions
- Many Otolaryngology-Head and Neck Surgery Subspecialties Relocate to Vanderbilt Health One Hundred OaksSeptember 4th, 2024
- Cutting-Edge Advances in Cancer Treatment Are Underway. Here Are 3 That Could Change LivesApril 20th, 2023
- Study Tracks Smell, Taste Loss Associated with COVIDSeptember 23rd, 2021
- Join now to see all
Grant Support
- 8th Annual Conference On Head And Neck CancerNational Institute Of Dental &Craniofacial Research2012
- CD147 As A Novel Target In Head And Neck CancerNational Cancer Institute2010–2012
- Fluorescently Labeled Anti-Egfr To Guide Removal Of Lymph Node MetastasisNational Institute Of Dental &Craniofacial Research2009–2010
- Tumor Stromal Interactions In Head And Neck CancerNational Cancer Institute2005–2009
- Role Of Fibroblast-Derived MT1-MMP In Oral CancerNational Institute Of Dental &Craniofacial Research2005–2006
Professional Memberships
- Fellow
- Member
- Collegium Oto-Rhino-Laryngologicum Amicitiae SacrumMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: